Economic Evaluation in Genomic and Precision Medicine

Mitropoulou, Christina

Pricing & Availability
Available: 0
List Price:$125.00

Email this title to a friend

Printer friendly version

Other formats:

Book Information
Edition:	1st
Publisher:	Academic Press, Incorporated
ISBN:	0-12-813382-1 (0128133821)
ISBN-13:	978-0-12-813382-8 (9780128133828)
Binding:	Softcover
Copyright:	2020
Publish Date:	04/23
Weight:	0.00 Lbs.
Pages:	264
Subject Class:	GEN (Genetics)
Return Policy:	Returns accepted up to 90 days provided no other recalls or return restrictions apply.
ProQuest Ebook Central:	Available in ProQuest Ebook Central™ View

Class Specifications

Abstract:

With Economic Evaluation in Genomic and Precision Medicine editors Christina Mitropoulou, George Patrinos, Sarah Wordsworth, and James Buchanan have provided an in-depth examination of essential concepts, protocols, and applications of economic evaluation in genomic and precision medicine. Contributions from leading international medical geneticists and health economists discuss how to effectively assess the costs and outcomes of different genomic care pathways, implement cost-effective medical interventions, and generally enhance the value of genomic and precision healthcare. Foundational chapters and discipline-specific case studies cover topics ranging from economic analysis of genomic trial design to health technology assessment of next-generation sequencing, ethical aspects, economic policy in genomic medicine, and pricing and reimbursement in clinical genomics. Here health economists will learn to apply sound economic analysis to precision medicine, and healthcare professionals and clinical researchers will discover methods to better assess the value of genomic diagnostics and improve clinical genomic practice and drug discovery. Introduces clinicians, researchers, and students to essential genomic and precision medicineDemonstrates through foundational chapters and discipline-specific case studies how to assess the relative costs and outcomes of different genomic care pathways and implement cost-effective budgetsEstablishes clear precedents for how genomic technologies can be leveraged to simultaneously reduce costs and enhance the value of healthcareFeatures contributions from leading international medical geneticists and health economists that are actively evolved in economic assessment of genomic and precision medicineProvides in-depth course material for professional, graduate, and undergraduate courses, examining innovative applications of economic evaluation in diverse clinical settings

Follow Matthews Book Co. on: